Sean Russell, Chair of ARM's Regulatory Advisory Group and Managing Partner at PrimeRA Pharma Partners, is speaking at “The Product is the Process - Is it?” 2026 in Potsdam, Germany, on 2 December 2026.
Presentation: “From Pharma Revision to Biotech Act: How to improve the EU regulatory landscape for ATMPs”
This one-day symposium looks at how advanced therapy medicinal products (ATMPs) and tissue- and cell-based products are manufactured and brought to the clinic. It has run since 2013 and brings together researchers, industry and regulators. The Paul-Ehrlich-Institut is one of the organisers.
The programme covers stem cell products in the clinic, product control, sequencing, EU tissue rules, immunotherapy for autoimmune disease, viral-vector manufacturing, cell therapy platforms and raw materials.
If you are attending and would like to arrange a meeting, please get in touch with Sean or the PrimeRA Pharma Partners team.